Improving bladder cancer treatment with new imaging and immune therapy methods
Advancing Bladder Cancer Care by Imaging and Intravesical Immune Checkpoint Blockade
['FUNDING_R21'] · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · NIH-10592433
This study is looking to improve how we find and treat bladder cancer by using better imaging techniques and new ways to deliver immunotherapy directly into the bladder, making it easier for patients to get the care they need.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PITTSBURGH AT PITTSBURGH (nih funded) |
| Locations | 1 site (PITTSBURGH, UNITED STATES) |
| Trial ID | NIH-10592433 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the detection and treatment of bladder cancer by developing advanced imaging techniques and intravesical immunotherapy. Current imaging methods struggle to identify aggressive tumors and their vascular structures, which can lead to missed diagnoses and treatment opportunities. The study aims to improve visualization of tumors and assess the effectiveness of intravesical therapies that could replace traditional injectable treatments. By using a specific carcinogen to provoke tumor growth, the researchers will explore how drug delivery can be optimized for better patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with bladder cancer, particularly those with aggressive forms of the disease or those who have not responded to standard treatments.
Not a fit: Patients with non-malignant bladder conditions or those who are not diagnosed with bladder cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective early detection and treatment options for bladder cancer patients.
How similar studies have performed: Previous research has shown promise in using advanced imaging and immunotherapy approaches for cancer treatment, indicating potential for success in this novel application.
Where this research is happening
PITTSBURGH, UNITED STATES
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH — PITTSBURGH, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: TYAGI, PRADEEP — UNIVERSITY OF PITTSBURGH AT PITTSBURGH
- Study coordinator: TYAGI, PRADEEP
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Bladder Cancer, Urinary Bladder Cancer